Surgery Partners, Inc. (NASDAQ:SGRY) Shares Bought by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC boosted its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 44.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 998,505 shares of the company's stock after acquiring an additional 309,481 shares during the quarter. Silvercrest Asset Management Group LLC owned 0.79% of Surgery Partners worth $21,138,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. KBC Group NV boosted its stake in shares of Surgery Partners by 66.1% during the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares during the period. Point72 Asia Singapore Pte. Ltd. lifted its holdings in Surgery Partners by 12.1% during the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after buying an additional 465 shares in the last quarter. MeadowBrook Investment Advisors LLC boosted its position in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after buying an additional 1,460 shares during the period. Tower Research Capital LLC TRC boosted its position in Surgery Partners by 279.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after buying an additional 7,925 shares during the period. Finally, Empowered Funds LLC purchased a new stake in Surgery Partners in the 4th quarter valued at about $245,000.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SGRY. Macquarie lowered their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research report on Tuesday, March 11th. Royal Bank of Canada reissued an "outperform" rating and issued a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Benchmark reiterated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a report on Monday, April 21st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $34.75.

Insider Buying and Selling at Surgery Partners

In other news, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. This represents a 4.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO David T. Doherty sold 6,733 shares of the firm's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at approximately $3,623,849.36. This trade represents a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.30% of the stock is currently owned by company insiders.

Surgery Partners Stock Down 1.7%

Shares of NASDAQ SGRY traded down $0.40 during mid-day trading on Tuesday, reaching $23.20. 2,877,568 shares of the company were exchanged, compared to its average volume of 1,099,830. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of -48.33, a P/E/G ratio of 19.21 and a beta of 1.96. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $33.97. The firm has a 50-day moving average of $22.55 and a 200 day moving average of $23.11.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. During the same quarter last year, the company earned $0.10 earnings per share. The company's revenue for the quarter was up 8.2% compared to the same quarter last year. On average, research analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.